Found 2 bookmarks
Custom sorting
SARS-CoV-2 affects Alzheimer’s disease
SARS-CoV-2 affects Alzheimer’s disease

"Patients suffering from COVID-19 have been found to exhibit dementia-related biomarkers.. The findings of this study suggest a potential link between mild-to-moderate SARS-CoV-2 infection and the initiation or acceleration of brain β-amyloid pathology, and hint at the possibility of an increased future incidence of Alzheimer’s disease subsequent to the COVID-19 pandemic."

·nature.com·
SARS-CoV-2 affects Alzheimer’s disease
Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection
Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection

UK study of 1,252 people finds SARS-CoV-2 may accelerate Alzheimer’s-related brain changes.

Infected individuals showed shifts in key biomarkers, with greater effects in hospitalized patients and those with hypertension.

we measured plasma biomarkers linked to Alzheimer’s disease pathology in the UK Biobank before and after serology-confirmed SARS-CoV-2 infections. SARS-CoV-2 infection was associated with biomarkers associated with β-amyloid pathology: reduced plasma Aβ42:Aβ40 ratio and, in more vulnerable participants, lower plasma Aβ42 and higher plasma pTau-181.
·nature.com·
Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection